Rights and permissions
About this article
Cite this article
Preliminary imatinib decision comes under fire in the UK. Pharmacoecon. Outcomes News 454, 4 (2004). https://doi.org/10.2165/00151234-200404540-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404540-00008